SPDR S&P Biotech ETF (XBI)
80.23
-0.66 (-0.82%)
At close: Apr 25, 2025, 3:20 PM
-0.82% (1D)
| Bid | 80.22 |
| Market Cap | 5.07B |
| AUM | 4.82B |
| NAV | 77.71 |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Shares Out | 65.83M |
| Inception Date | Jan 31, 2006 |
| Ask | 80.23 |
| Volume | 7.08M |
| Open | 80.06 |
| Previous Close | 80.89 |
| Day's Range | 79.27 - 80.73 |
| 52-Week Range | 66.66 - 105.47 |
| Holdings | 128 |
| Expense Ratio | 0.35% |
About XBI
The SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select IndustryTM Index (the “Index”)Seeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: BiotechnologySeeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocksAllows investors to take strategic or tactical positions at a more targeted level than traditional sector based investing
Asset Class Equity
Ticker Symbol XBI
Inception Date Jan 31, 2006
Provider State Street
Website Fund Home Page
Top 10 Holdings 25.48% of assets
| Name | Symbol | Weight |
|---|---|---|
| Natera, Inc. | NTRA | 2.70% |
| Vertex Pharmaceutica... | VRTX | 2.67% |
| Alnylam Pharmaceutic... | ALNY | 2.64% |
| Insmed Incorporated | INSM | 2.60% |
| United Therapeutics ... | UTHR | 2.58% |
| Exact Sciences Corpo... | EXAS | 2.57% |
| Neurocrine Bioscienc... | NBIX | 2.52% |
| Gilead Sciences, Inc... | GILD | 2.50% |
| Amgen Inc. | AMGN | 2.41% |
| Regeneron Pharmaceut... | REGN | 2.29% |
Dividends Dividend Yield 0.03%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Mar 24, 2025 | $0.0053 | Mar 26, 2025 |
| Dec 23, 2024 | $0.0027 | Dec 26, 2024 |
| Sep 23, 2024 | $0.0152 | Sep 25, 2024 |
| Jun 24, 2024 | $0.1148 | Jun 26, 2024 |
| Dec 18, 2023 | $0.0139 | Dec 21, 2023 |
